ZetrOZ Systems Brings sam® Ultrasound Soft Tissue Healing Innovation to 8th Annual Interventional Orthobiologics Foundation SCOTTSDALE, Ariz., Feb. 16, 2023 (GLOBE NEWSWIRE) -- ZetrOZ Systems announces that the company is participating in the 8th Annual Interventional Orthobiologics Foundation (IOF) Conference at the...

Doctors at Michigan Center for Regenerative Medicine Applaud Revolutionary sam® Device for Improving Soft Tissue Healing ROCHESTER, Mich., Nov. 15, 2022 (GLOBE NEWSWIRE) -- ZetrOZ Systems' sam® device continues to garner national attention from physicians for its efficacy in promoting soft tissue healing and relieving...

ZetrOZ Systems Presented at the Annual PHATS/SPHEM 2022 Conference TRUMBULL, Conn., Aug. 17, 2022 (GLOBE NEWSWIRE) -- ZetrOZ founder and CEO George Lewis, Ph.D., spoke at the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of...

ZetrOZ Shares Insights for Providers and Patients Seeking Insurance Coverage on Novel Medical Technologies for Advanced Treatments TRUMBULL, Conn., June 28, 2022 (GLOBE NEWSWIRE) -- New medical technologies bring better outcomes to patients and more efficiency to the U.S. healthcare industry, but some insurers and care...